lenalidomide has been researched along with Aging in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Au-Yeung, R; Hwang, YY; Kwong, YL; Lau, HP | 1 |
| Ali, A; Montoro, J; Raza, A; Yerlikaya, A | 1 |
| Boccadoro, M; Bringhen, S; Cavo, M; Conticello, C; Cuomo, C; D'Arena, G; Gay, F; Grossi, A; Guariglia, R; Larocca, A; Milone, G; Morabito, F; Musto, C; Musto, P; Offidani, M; Palumbo, A; Petrucci, MT; Pietrantuono, G; Simeon, V; Tacchetti, P; Villani, O; Zamagni, E | 1 |
| Ershler, WB; Ferrucci, L; Goetzl, EJ; Greig, NH; Huang, MC; Longo, DL; Luo, W; Schwartz, JB; Tweedie, D | 1 |
1 review(s) available for lenalidomide and Aging
| Article | Year |
|---|---|
Improving Treatment for Myelodysplastic Syndromes Patients.
Topics: Aging; Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Enzyme Inhibitors; Humans; Lenalidomide; Myelodysplastic Syndromes; Stem Cell Transplantation; Transplantation, Homologous | 2018 |
3 other study(ies) available for lenalidomide and Aging
| Article | Year |
|---|---|
Complete response of age-related Epstein-Barr virus-associated polymorphic nodal lymphoproliferative disease of plasmacytic type to low-dose lenalidomide.
Topics: Aged, 80 and over; Aging; Antigens, CD; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Lenalidomide; Lymph Nodes; Lymphoproliferative Disorders; Male; Plasma Cells; Positron Emission Tomography Computed Tomography; Thalidomide | 2018 |
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Ital
Topics: Aged; Aging; Antigens, CD34; Biomarkers; Cell Count; Cell Separation; Cyclophosphamide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Induction Chemotherapy; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Retrospective Studies; Thalidomide; Transplantation, Autologous; Treatment Failure | 2015 |
Preferential enhancement of older human T cell cytokine generation, chemotaxis, proliferation and survival by lenalidomide.
Topics: Adult; Aged; Aging; bcl-X Protein; Cell Proliferation; Cell Survival; Cells, Cultured; Chemokine CCL21; Chemotaxis; Cytokines; Female; Humans; Lenalidomide; Lymphocyte Activation; Male; Monocytes; T-Lymphocytes; Thalidomide; Young Adult | 2011 |